Psychedelic-Based Treatment

What is psychedelic-based treatment?

Psychedelic-based treatment refers to the use of a psychedelic substance (e.g. MDMA, psilocybin, DMT, LSD, ketamine, ibogaine) as part of an FDA-approved, therapist-supervised prescription treatment. Psychdelic-based treatments have shown therapeutic promise in treating an array of mental conditions, including PTSD, treatment-resistant depression, addiction, anorexia, anxiety, obsessive-compulsive disorder (OCD), and even Alzheimer’s and Lyme disease syndrome. One of the first psychedelic-based treatments could be MDMA-assisted therapy, which is going through clinical trials and could become widely available as soon as 2023.